Suvretta Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Suvretta Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.59M	Hold	13,400	–	–	0.17%	56
2025 Q4	$7.76M	Hold	13,400	–	–	0.16%	66
2025 Q3	$6.5M	Buy	13,400 +5,500	+70%	+$2.56M	0.17%	66
2025 Q2	$3.2M	Hold	7,900	–	–	0.1%	69
2025 Q1	$3.93M	Hold	7,900	–	–	0.15%	67
2024 Q4	$4.11M	Buy	7,900 +640	+9%	+$352K	0.14%	67
2024 Q3	$4.49M	Hold	7,260	–	–	0.14%	65
2024 Q2	$4.01M	Hold	7,260	–	–	0.15%	58
2024 Q1	$4.22M	Hold	7,260	–	–	0.16%	64
2023 Q4	$3.85M	Hold	7,260	–	–	0.17%	55
2023 Q3	$3.67M	Hold	7,260	–	–	0.2%	56
2023 Q2	$3.79M	Buy	7,260 +2,200	+43%	+$1.19M	0.2%	65
2023 Q1	$2.92M	Buy	5,060 +1,700	+51%	+$958K	0.12%	62
2022 Q4	$1.85M	Sell	3,360 -111,365	-97%	-$59M	0.08%	66
2022 Q3	$58.2M	Sell	114,725 -6,650	-5%	-$3.72M	2.42%	18
2022 Q2	$65.9M	Buy	121,375 +6,306	+5%	+$3.47M	2.51%	14
2022 Q1	$68M	Sell	115,069 -155,401	-57%	-$89.3M	2.08%	21
2021 Q4	$180M	Sell	270,470 -55,340	-17%	-$34.6M	3.49%	8
2021 Q3	$186M	Buy	+325,810	New	+$179M	3.14%	9
2015 Q1	–	Sell	-468,500	Closed	-$58.7M	–	37
2014 Q4	$58.7M	Buy	468,500 +70,800	+18%	+$8.61M	4.18%	11
2014 Q3	$48.4M	Buy	397,700 +164,100	+70%	+$20M	4.23%	8
2014 Q2	$27.6M	Sell	233,600 -15,900	-6%	-$1.87M	2.49%	22
2014 Q1	$30M	Sell	249,500 -72,500	-23%	-$8.62M	3.57%	13
2013 Q4	$35.9M	Buy	+322,000	New	+$32M	4.81%	3

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Suvretta Capital Management's TMO Position: Q1 2026 in Review

Suvretta Capital Management held its Thermo Fisher Scientific (TMO) position steady in Q1 2026 at 13,400 shares worth $6.59M. The position accounts for 0.17% of the portfolio, ranked #56.

Suvretta Capital Management first reported a position in TMO in Q4 2013 and has held it in 24 quarters since. The position peaked at $186M in Q3 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Suvretta Capital Management held 13,400 shares of Thermo Fisher Scientific worth $6.59M as of Q1 2026.
Suvretta Capital Management left its Thermo Fisher Scientific share count unchanged in Q1 2026.
Thermo Fisher Scientific made up 0.17% of Suvretta Capital Management's portfolio in Q1 2026, its #56 holding.
Suvretta Capital Management first reported a position in Thermo Fisher Scientific in Q4 2013 and has held it in 24 quarters since.
Suvretta Capital Management's Thermo Fisher Scientific position peaked at $186M in Q3 2021.
2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Suvretta Capital Management's 13F filing for Q1 2026, filed 15 May 2026.